CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹1,896 Cr | ₹1,691 Cr | ₹1,405 Cr | ₹1,168 Cr | ₹982 Cr |
What is the latest Profit & Loss Account Balance ratio of CONCORD BIOTECH ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹1,896 Cr |
| Mar2025 | ₹1,691 Cr |
| Mar2024 | ₹1,405 Cr |
| Mar2023 | ₹1,168 Cr |
| Mar2022 | ₹982 Cr |
How is Profit & Loss Account Balance of CONCORD BIOTECH Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,896 Cr | 12.11 | |
| Mar2025 | ₹1,691 Cr | 20.36 | |
| Mar2024 | ₹1,405 Cr | 20.25 | |
| Mar2023 | ₹1,168 Cr | 19.03 | |
| Mar2022 | ₹982 Cr | - | |
Compare Profit & Loss Account Balance of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,626.2 Cr | -0.9% | -5.8% | -10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -0.9% |
-5.8% |
-10.6% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses